ANX-042

DRUG2 trials

Sponsors

Mayo Clinic

Conditions

Cardiorenal DiseaseHealthy VolunteersHeart FailureRenal Disfunction

Phase 1

ANX-042 Healthy Volunteer Dose Escalation Study

CompletedNCT01638104

Mayo ClinicHealthy Volunteers

Start: 2012-08-31End: 2012-12-31Updated: 2017-10-13

Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

CompletedNCT03019653

Mayo ClinicCardiorenal Disease, Heart Failure, Renal Disfunction

Start: 2017-01-31End: 2024-09-13Updated: 2024-11-15